Combined effect of naringin and adipose tissue-derived mesenchymal stem cell on cisplatin nephrotoxicity through Sirtuin1/Nrf-2/HO-1 signaling pathway: a promising nephroprotective candidate

Author:

Amini NeginORCID,Nejaddehbashi Fereshteh,Badavi Mohammad,Bayati Vahid,Zahra Basir

Funder

Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Reference47 articles.

1. Amini N, Sarkaki A, Dianat M, Mard SA, Ahangarpour A, Badavi M (2019a) Protective effects of naringin and trimetazidine on remote effect of acute renal injury on oxidative stress and myocardial injury through Nrf-2 regulation. Pharmacol Rep 71:1059–1066

2. Amini N, Sarkaki A, Dianat M, Mard SA, Ahangarpour A, Badavi M (2019b) The renoprotective effects of naringin and trimetazidine on renal ischemia/reperfusion injury in rats through inhibition of apoptosis and downregulation of micoRNA-10a. Biomed Pharmacother 112:108568. https://doi.org/10.1016/j.biopha.2019.01.029. Epub 2019 Feb 16

3. Arab HH, Ashour AM, Eid AH, Arafa E-SA, Al Khabbaz HJ, Abd El-Aal SA (2022) Targeting oxidative stress, apoptosis, and autophagy by galangin mitigates cadmium-induced renal damage: role of SIRT1/Nrf2 and AMPK/mTOR pathways. Life Sci 291:120300. https://doi.org/10.1016/j.lfs.2021.120300. Epub 2022 Jan 7

4. Awadalla A, Hussein AM, El-Far YM, El-Senduny FF, Barakat N, Hamam ET, Abdeen HM, El-Sherbiny M, Serria MS, Sarhan AA (2022) Rapamycin improves adipose-derived mesenchymal stem cells (ADMSCs) renoprotective effect against cisplatin-induced acute nephrotoxicity in rats by inhibiting the mTOR/AKT signaling pathway. Biomedicines 10:1295. https://doi.org/10.3390/biomedicines10061295

5. Balaha MF, Alamer AA, Eisa AA, Aljohani HM (2023) Shikonin alleviates gentamicin-induced renal injury in rats by targeting renal endocytosis, SIRT1/Nrf2/HO-1, TLR-4/NF-κB/MAPK, and PI3K/Akt cascades. Antibiotics 12(5):826. https://doi.org/10.3390/antibiotics12050826

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3